Yes, but I think the market will give it more credit for growth in the future (re-rate) and at 1.5 times that 351m book at 526m is still a yield of 8%, and the ROE is higher than that 12% at about 15%+, which is ultimately what compounds shareholders equity and NPAT, thus the share price. Not withstanding the risk that debt brings.
I also reckon that cash on hand deployed that ROE will increase, plus the opportunity to reduce funding costs in future and increased scale driving higher margins. I think ROE could grow to 17.5%+.
Ann: MNY enters NZ Market and exits SACC with sale for $46m, page-16
Add SVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
0.010(0.75%) |
Mkt cap ! $279.2M | |||
| Open | High | Low | Value | Volume |
| $1.34 | $1.36 | $1.33 | $229.8K | 171.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2248 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 9687 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| SVR (ASX) Chart |